Intrinsic Value of S&P & Nasdaq Contact Us

The Ensign Group, Inc. ENSG NASDAQ

NASDAQ Global Select • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
58/100
3/7 Pass
SharesGrow Intrinsic Value
$157.17
-20.8%
Analyst Price Target
$222.33
+12%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

The Ensign Group, Inc. (ENSG) trades at a trailing P/E of 33.9, forward P/E of 26.4. Trailing earnings yield is 2.95%, forward earnings yield 3.79%. PEG 2.40. Graham Number is $72.23.

Criteria proven by this page:

  • VALUE (29/100, Fail) — PEG > 2.0 means the stock is expensive even after accounting for growth (PEG 2.40).
  • Forward P/E 26.4 (down from trailing 33.9) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 2.40 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield 2.95% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.79% as earnings recover.
  • Analyst consensus target $222.33 (+12% upside) — modest upside expected.

Overall SharesGrow Score: 58/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
58/100
SG Score
View full scorecard →
VALUE
29/100
Price-to-Earnings & upside
Proven by this page
FUTURE
61/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
43/100
→ Income
GROWTH
80/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — ENSG

Valuation Multiples
P/E (TTM)33.9
Forward P/E26.4
PEG Ratio2.40
Forward PEG0.92
P/B Ratio5.21
P/S Ratio2.33
EV/EBITDA27.1
Per Share Data
EPS (TTM)$5.97
Forward EPS (Est.)$7.52
Book Value / Share$38.81
Revenue / Share$87.84
FCF / Share$6.44
Yields & Fair Value
Earnings Yield2.95%
Forward Earnings Yield3.79%
Dividend Yield0.13%
Graham Number$72.23
SharesGrow IV$157.17 (-20.8%)
Analyst Target$222.33 (+12%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 21.0 -2.10 2.30 0.63 0.78%
2017 26.1 -1.29 2.15 0.66 0.82%
2018 20.4 0.16 3.19 1.08 0.50%
2019 21.9 1.35 3.71 1.19 0.42%
2020 22.9 0.42 4.76 1.62 0.28%
2021 23.5 1.97 4.48 1.74 0.25%
2022 23.1 1.59 4.16 1.72 0.23%
2023 29.9 -3.70 4.19 1.68 0.21%
2024 25.3 0.63 4.10 1.77 0.18%
2025 29.0 2.06 4.47 1.97 0.14%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.96 $1.65B $49.99M 3%
2017 $0.77 $1.85B $40.48M 2.2%
2018 $1.70 $2.07B $92.36M 4.5%
2019 $1.97 $2.04B $110.53M 5.4%
2020 $3.06 $2.4B $170.48M 7.1%
2021 $3.42 $2.63B $194.65M 7.4%
2022 $3.95 $3.03B $224.68M 7.4%
2023 $3.65 $3.73B $209.4M 5.6%
2024 $5.12 $4.26B $297.97M 7%
2025 $5.84 $5.06B $343.97M 6.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $7.52 $7.51 – $7.57 $5.79B $5.75B – $5.82B 3
2027 $8.24 $8.00 – $8.47 $6.34B $6.3B – $6.39B 3
2028 $8.98 $8.89 – $9.07 $6.9B $6.9B – $6.9B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message